CurrentRheuma
Get Weekly

Topic · page 5 of 11

Inflammatory myopathies

Dermatomyositis, polymyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, inclusion body myositis, myositis-specific antibodies, myositis-associated interstitial lung disease and cancer-associated myositis

Briefs 161–200 of 430 placed here, newest publication first

Briefs in Inflammatory myopathies

Newest publication first

  1. Clin Exp Rheumatol

    Clinical phenotypes and long-term outcomes of anti-SRP versus anti-HMGCR immune-mediated necrotising myopathy: a 13-year single-centre study

    Cohort study

  2. Arthritis Res Ther

    Nailfold videocapillaroscopy findings are associated with IIM subtypes and IFN activation

    Cross-sectional study

  3. Ann Rheum Dis

    The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project

    Diagnostic or prognostic study

  4. Rheumatology (Oxford)

    A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis

    Meta-analysis

  5. Semin Arthritis Rheum

    Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study

    Cohort study

  6. Scand J Rheumatol

    Cardiovascular risk and cardiac involvement in idiopathic inflammatory myopathies: insights from a cross-sectional Swedish single-centre study

    Cross-sectional study

  7. RMD Open

    Cardiovascular events in patients with myositis: results from a French retrospective cohort

    Cohort study

  8. Clin Exp Rheumatol

    Infections preceding diagnosis associated with myositis phenotypes in a national patient registry

    Cross-sectional study

  9. Arthritis Res Ther

    Plasma levels of adhesion molecules are elevated in dermatomyositis-interstitial lung disease and associated with low paraoxonase-1 activity

    Cross-sectional study

  10. Arthritis Res Ther

    Enhanced systemic oxidative stress response in patients with idiopathic inflammatory myopathies

    Cross-sectional study

  11. Arthritis Res Ther

    Vitamin D and its receptor in skeletal muscle are associated with muscle disease manifestation, lipid metabolism and physical fitness of patients with myositis

    Cross-sectional study

  12. Clin Exp Rheumatol

    Short Form 36 (SF-36) health survey questionnaire in health-related quality of life assessment in patients with inflammatory myopathies

    Diagnostic or prognostic study

  13. Semin Arthritis Rheum

    External validation of the 2017 EULAR/ACR classification criteria for idiopathic inflammatory myopathies in anti-MDA5 antibody-positive interstitial lung disease patients: A multicenter retrospective cohort study in China

    Cohort study

  14. Clin Exp Rheumatol

    Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomol

    Secondary analysis

  15. Clin Exp Rheumatol

    Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale

    Trial design

  16. Clin Exp Rheumatol

    Challenges in international investigator-led rare disease clinical trials and the case for optimism in inclusion body myositis

    Randomized controlled trial

  17. Clin Exp Rheumatol

    Infections as a predominant cause of death in adult patients with idiopathic inflammatory myopathies

    Cohort study

  18. Arthritis Res Ther

    Toward digitally supported self-assessment of patients with idiopathic inflammatory myopathies

    Cohort study

  19. Arthritis Rheumatol

    Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial

    Randomized controlled trial

  20. Rheumatology (Oxford)

    Cut-off matters in the interpretation of myositis antibodies by line immunoassay

    Diagnostic or prognostic study

  21. Arthritis Res Ther

    Clinical features and survival analysis of 40 cases of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease

    Cohort study

  22. Arthritis Rheumatol

    Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta‐Analyses

    Meta-analysis

  23. Clin Exp Rheumatol

    Pneumocystis jirovecii pneumonia in anti-MDA5-positive dermatomyositis: characterisation, risk factors and prognosis

    Cohort study

  24. Arthritis Res Ther

    Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype

    Mechanistic study

  25. Clin Exp Rheumatol

    Cardiac involvement in patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis

    Cohort study

  26. Rheumatology (Oxford)

    Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study

    Secondary analysis

  27. Clin Exp Rheumatol

    Analysis of clinical features and risk factors for patients with idiopathic inflammatory myopathy complicated by Pneumocystis jirovecii pneumonia

    Cohort study

  28. Rheumatology (Oxford)

    Tacrolimus as first-line therapy in a US cohort of idiopathic inflammatory myopathies related interstitial lung disease

    Cohort study

  29. Ann Rheum Dis

    Mitochondrial transplantation as a novel therapeutic approach in idiopathic inflammatory myopathy

    Mechanistic study

  30. Semin Arthritis Rheum

    Refractory cutaneous ulcers in anti-MDA5 dermatomyositis were not associated with rapidly progressive interstitial lung disease, and responded to tadalafil

    Cohort study

  31. Rheumatology (Oxford)

    Tofacitinib treatment for active dermatomyositis and anti-synthetase syndrome: a prospective cohort pilot study

    Cohort study

  32. RMD Open

    Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review

    Meta-analysis

  33. RMD Open

    Predictive value of myositis antibodies: role of semiquantitative classification and positivity for more than one autoantibody

    Cohort study

  34. J Rheumatol

    Epidemiology of Antisynthetase Syndrome and Risk of Malignancy in a Population-Based Cohort (1998-2019)

    Cohort study

  35. Lancet

    Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

    Randomized controlled trial

  36. Arthritis Res Ther

    Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

    Cross-sectional study

  37. Rheumatology (Oxford)

    Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training

    Mechanistic study

  38. Ann Rheum Dis

    Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy

    Mechanistic study

  39. Arthritis Care Res (Hoboken)

    Occupational and Hobby Exposures Associated With Myositis Phenotypes in a National Myositis Patient Registry

    Cross-sectional study

  40. Semin Arthritis Rheum

    Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies

    Cohort study

All 430 Briefs in ExploreShowing Briefs 161–200 of 430, newest first